On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
BCAC is thrilled at the results of a New Zealand study that found a special silicone dressing can help to dramatically reduce skin damage during radiation therapy for breast cancer.
The research, carried out by the Department of Radiotherapy at the University of Otago, has found that placing a special silicone film called Mepitel Film over the area to be irradiated can reduce skin reactions to radiation therapy by more than 90 per cent.
Renewed questions have been raised about the value of mammograms after a Canadian study suggested that it does not reduce the number of deaths from breast cancer.
BCAC chair Libby Burgess says while the latest research is thought-provoking, it should in no way prompt New Zealand women to stop getting their free mammograms every two years through BreastScreen Aotearoa.
New research suggests that young women who smoke more than a pack of cigarettes a day have a much higher risk of developing the most common type of breast cancer.
The study, published in the journal Cancer, shows that young women who smoke are 30 per cent more likely to develop oestrogen receptor positive breast cancer, compared with those who have never smoked.
The coming year will be a challenging one for breast cancer physicians and researchers as new figures show that the number of breast cancer cases worldwide is on the rise.
The World Health Organisation’s International Agency for Research on Cancer (IARC) recently released the latest global statistics on cancer incidence, mortality and prevalence.
Breast cancer survivors taking aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane experienced a reduction in joint pain if they exercise while on treatment, according to results presented at the 2013 San Antonio Breast Cancer Symposium, which is currently underway.
When a woman is diagnosed with breast cancer it is not only she who embarks on an unexpected and unwelcome journey – her partner will also inevitably experience their own challenging cancer journey.
It has been very exciting to track down Dr Elizabeth Iorns – a scientist who is conducting ground-breaking experiments in America to reduce the genetic transmission of BRCA – and realise that she grew up in New Zealand!
New research shows that a lack of clinical trials aimed specifically at younger breast cancer patients leaves knowledge gaps that could be partly to blame for their poorer survival rates.
The study, by Cancer Research UK study published in the Journal of the National Cancer Institute, analysed almost 3000 British women diagnosed with breast cancer under the age of 40.
A Missouri University of Science and Technology researcher has developed a new screening method that uses urinalysis to diagnose breast cancer – and determine its severity – before it could be detected with a mammogram.
UK scientists have discovered a number of genes which are responsible for developing resistance to a targeted medicine used in the treatment of HER2-Positive breast cancer.
The team at the Institute of Cancer Research in London examined a number of genes that were overactive in women with HER2 Positive breast cancer who had developed a resistance to the drug Lapatinib (Tykerb).